SCHEMBL2944503

SCHEMBL2944503

CCCCCCCCCCC(CCCCCCC(=O)O)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.69
FFAR1 O14842 2/20 0.69
GPR84 Q9NQS5 7/20 0.68
PPARG P37231 7/20 0.68
PPARD Q03181 7/20 0.68
PPARA Q07869 7/20 0.68
HDAC11 Q96DB2 5/20 0.68
TSHR P16473 4/20 0.68
PTPN1 P18031 3/20 0.68
ALDH1A1 P00352 3/20 0.68
TLR2 O60603 2/20 0.68
TDP1 Q9NUW8 2/20 0.68
FABP4 P15090 2/20 0.68
KMT2A Q03164 2/20 0.68
SLC22A6 Q4U2R8 1/20 0.68
SLC22A8 Q8TCC7 1/20 0.68
MEN1 O00255 1/20 0.68
ESR1 P03372 1/20 0.68
ALOX15 P16050 1/20 0.68
PDE4A P27815 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5478771 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL6157312 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL6157756 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
Behenic Acid SCHEMBL20658937 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
Palmitic Acid SCHEMBL20876307 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
Myristic Acid SCHEMBL25309729 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
Undecanoate SCHEMBL20394139 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL5820201 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL6158348 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD
SCHEMBL5575716 1.00 FFAR4 (0.69) FFAR4FFAR1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049550-B1 METHOD FOR PRODUCING COPPER-CONTAINING ORGANOMETALLIC FRAMEWORK MATERIAL BASF SE (DE) 2010-01-06 EP disclosed
US-20090306420-A1 PROCESS FOR PREPARING COPPER-COMPRISING METAL ORGANIC FRAMEWORKS BASF SE (DE) 2009-12-10 US disclosed
EP-1204693-B1 POLYESTERCARBONATE COMPRISING RESIDUES OF BRANCHED DIACIDS GEN ELECTRIC (US) 2005-02-09 EP disclosed
EP-1204693-A1 POLYESTERCARBONATE COMPRISING RESIDUES OF BRANCHED DIACIDS GENERAL ELECTRIC COMPANY (US) 2002-05-15 EP disclosed
WO-2001009222-A1 POLYESTERCARBONATE COMPRISING RESIDUES OF BRANCHED DIACIDS GENERAL ELECTRIC COMPANY (US) 2001-02-08 WO disclosed
US-6143858-A REACTING INTERFACIALLY A DIHYDRIC PHENOL, A CARBONATE PRECURSOR, AND A BRANCHED ALIPHATIC DICARBOXYLIC ACID OF 10 TO ABOUT 40 CARBON ATOMS, AND RAISING THE PH FOR THE REMAINDER OF THE CARBONATE PRECURSOR TIME; LOW MELT VISCOSITY GENERAL ELECTRIC COMPANY (US) 2000-11-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306420-A1 PROCESS FOR PREPARING COPPER-COMPRISING METAL ORGANIC FRAMEWORKS AOC1, AOC2, AOC3 FFAR4 2192/4885FFAR1 1693/4885GPR84 4510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.